Two-year Study Results: NuVasive Simplify Cervical Disc

NuVasive Simplify Cervical Disc

Two-level FDA Investigational Device Exemption study data reiterates that NuVasive's Simplify Disc has a significantly greater success rate at 24-month follow-up compared to anterior cervical discectomy and fusion (ACDF) when used for two-level cervical total disc replacement (cTDR).

Findings from this study include:

Overall composite success...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us